Geron Corp. (GERN)
1.33
-0.03
(-2.21%)
USD |
NASDAQ |
Dec 15, 16:00
1.33
0.00 (0.00%)
After-Hours: 06:33
Geron Research and Development Expense (Annual): 103.74M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Cassava Sciences, Inc. | 69.64M |
| SELLAS Life Sciences Group, Inc. | 19.10M |
| Rezolute, Inc. | 61.53M |
| GT Biopharma, Inc. | 5.798M |
| Ultragenyx Pharmaceutical, Inc. | 667.82M |